US Stock MarketDetailed Quotes
PRPO Precipio
- 6.1921
- -0.2479-3.85%
Close Nov 15 16:00 ET
9.18MMarket Cap-3421P/E (TTM)
6.2500High6.1921Low650Volume6.2500Open6.4400Pre Close4.05KTurnover0.05%Turnover RatioLossP/E (Static)1.48MShares7.600052wk High0.77P/B8.09MFloat Cap4.310052wk Low--Dividend TTM1.31MShs Float3241684.2586Historical High--Div YieldTTM0.90%Amplitude4.3100Historical Low6.2330Avg Price1Lot Size
About Precipio Company
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
Company Profile
SymbolPRPO
Company NamePrecipio
Listing DateJun 30, 2017
Issue Price15.00
Founded1997
CEOMr. Ilan Danieli
MarketNASDAQ
Employees57
Fiscal Year Ends12-31
Address4 Science Park,3rd Floor
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06511
Phone1-203-787-7888
Websitehttp://www.precipiodx.com
Company Executives
- Name
- Position
- Salary
- Ilan Danieli
- Director and Chief Executive Officer
- 473.44K
- Matthew Gage
- Chief Financial Officer and Principal Accounting Officer
- --
- Ayman A. Mohamed
- Chief Technology Officer
- 284.50K
- Ahmed Zaki Sabet
- Chief Operating Officer
- 265.34K
- Richard A. Sandberg
- Chairman of the Board
- 98.43K
- Christina Valauri
- Independent Director
- --
- Ronald A. Andrews, Jr
- Independent Director
- 60.81K
- David S. Cohen
- Independent Director
- 59.73K
- Kathleen D. Laporte
- Independent Director
- 72.81K
- Dr. Jeffrey Cossman, M.D.
- Independent Director
- 64.01K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data